FDA — authorised 29 January 1975
- Application: NDA017536
- Marketing authorisation holder: SCHERING
- Local brand name: DIPROSONE
- Indication: CREAM — TOPICAL
- Status: approved
🇺🇸 Betamethasone dipropionate cream in United States
FDA authorised Betamethasone dipropionate cream on 29 January 1975
Marketing authorisations
FDA — authorised 15 April 1976
- Application: NDA017691
- Marketing authorisation holder: SCHERING
- Local brand name: DIPROSONE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 1 February 1977
- Application: NDA017781
- Marketing authorisation holder: SCHERING
- Local brand name: DIPROSONE
- Indication: LOTION — TOPICAL
- Status: approved
FDA — authorised 27 July 1983
- Application: NDA018741
- Marketing authorisation holder: ORGANON
- Local brand name: DIPROLENE
- Indication: OINTMENT, AUGMENTED — TOPICAL
- Status: approved
FDA — authorised 31 January 1986
- Application: NDA019408
- Marketing authorisation holder: SCHERING
- Local brand name: DIPROLENE
- Indication: GEL, AUGMENTED — TOPICAL
- Status: approved
FDA — authorised 1 August 1988
- Application: NDA019716
- Marketing authorisation holder: ORGANON
- Local brand name: DIPROLENE
- Indication: LOTION, AUGMENTED — TOPICAL
- Status: approved
FDA
- Application: NDA017829
- Marketing authorisation holder: SCHERING
- Local brand name: DIPROSONE
- Indication: DISC — TOPICAL
- Status: approved
Other Dermatology approved in United States
Frequently asked questions
Is Betamethasone dipropionate cream approved in United States?
Yes. FDA authorised it on 29 January 1975; FDA authorised it on 15 April 1976; FDA authorised it on 1 February 1977.
Who is the marketing authorisation holder for Betamethasone dipropionate cream in United States?
SCHERING holds the US marketing authorisation.